Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews

Sponsor
National Cancer Institute (NCI) (NIH)
Overall Status
Completed
CT.gov ID
NCT00341900
Collaborator
Centers for Disease Control and Prevention (U.S. Fed), National Institute for Occupational Safety and Health (NIOSH/CDC) (U.S. Fed)
134
1
220.8
0.6

Study Details

Study Description

Brief Summary

Ionizing radiation efficiently induces chromosomal aberrations (CA) and several studies of CA have now been conducted among small groups of flight crews. However, most of the studies only evaluated the unstable aberrations that reflect recent exposures, but not long-term cumulative cosmic radiation exposure. Chromosome painting by fluorescence in situ hybridization (FISH) is a widely used and established cytogenetic method for detecting stable aberrations such as translocations. Thus, FISH can be used for estimating chromosomal damage from cumulative radiation exposure. No large studies of flight crews utilizing FISH have been conducted to date.

We propose a study to measure CA using FISH in a group of pilots estimated to have high comic radiation exposure based on flight histories, i.e., those with long duration flying international routes, and a comparison group of university faculty with minimal flying history. These measurements will be used to determine if pilots have elevated frequencies of CA (specifically stable translocations) as compared with the university faculty. In addition, the frequencies of CA will be examined in relation to the cumulative cosmic radiation dose to determine if there is a dose-response relationship. Individual cumulative doses will be calculated from pilot flight histories using a computer program developed by the FAA which estimates cosmic radiation does by accounting for changes in altitude and latitude, and the 11-year solar cycle at the time of the flight. We will collect information on age, lifestyle factors, diet, health history, family cancer history, and medical radiation exposures from personal interview and self-administered dietary questionaire. These factors may affect the CA frequency and so we plan to adjust for them in the statistical analyses.

Pilots will be identified based on the Allied Pilots Association roster and faculty from a commercial company that maintains a database of university faculty, including those in the Chicago area. Potential participants will be notified of the study by mail and recruited/screened for eligibility over the telephone. We will compensate participants $100 for their time. A field station will be set up at a medical or health clinic convenient to the participants, where interviews Will be conducted and a peripheral blood sample collected. Participants will be notified of the overall study results and may request their personal CA results at the end of the study. Participants may also choose to have additional blood drawn, however this blood sample will be anonymized so that it cannot be linked back to the participant. Genotypic variants in DNA repair (and possibly other) genes will be evaluated for an effect on CA frequency.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Ionizing radiation efficiently induces chromosomal aberrations (CA) and several studies of CA have now been conducted among small groups of flight crews. However, most of the studies only evaluated the unstable aberrations that reflect recent exposures, but not long-term cumulative cosmic radiation exposure. Chromosome painting by fluorescence in situ hybridization (FISH) is a widely used and established cytogenetic method for detecting stable aberrations such as translocations. Thus, FISH can be used for estimating chromosomal damage from cumulative radiation exposure. No large studies of flight crews utilizing FISH have been conducted to date.

    In collaboration with the National Institute for Occupational Safety and Health (NIOSH), we proposed a study to measure CA using FISH in a group of pilots estimated to have high comic radiation exposure based on flight histories, i.e., those with long duration flying international routes, and a comparison group of university faculty with minimal flying history. These measurements will be used to determine if pilots have elevated frequencies of CA (specifically stable translocations) as compared with the university faculty. In addition, the frequencies of CA will be examined in relation to the cumulative cosmic radiation dose to determine if there is a dose-response relationship. Individual cumulative doses will be calculated from pilot flight histories using a computer program developed by the FAA which estimates cosmic radiation does by accounting for changes in altitude and latitude, and the 11-year solar cycle at the time of the flight. We will collect information on age, lifestyle factors, diet, health history, family cancer history, and medical radiation exposures from a self-administered study and dietary questionnaire. These factors may affect the CA frequency and so we plan to adjust for them in the statistical analyses.

    Pilots were identified based on the Allied Pilots Association roster and faculty from a commercial company that maintains a database of university faculty, including those in the Chicago area. Potential participants will be notified of the study by mail and recruited/screened for eligibility over the telephone. We compensated participants $100 for their time and inconvenience. Two field stations were arranged at the O'Hare UIC medical clinic for pilots and at the UIC Health Services clinic (on campus) for the faculty, where interviews were conducted and a peripheral blood sample collected. Participants will be notified of the overall study results and may request their personal CA results at the end of the study. Participants may also choose to have additional blood drawn, however this blood sample will be anonymized so that it cannot be linked back to the participant. Genotypic variants in DNA repair (and possibly other) genes will be evaluated for an effect on CA frequency.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    134 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
    Actual Study Start Date :
    Nov 9, 2001
    Actual Primary Completion Date :
    Dec 31, 2016
    Actual Study Completion Date :
    Apr 3, 2020

    Arms and Interventions

    Arm Intervention/Treatment
    Case

    Male pilots with high cosmic radiation exposure

    Outcome Measures

    Primary Outcome Measures

    1. Chromosome translocation frequency [One time point]

      Chromosome translocation frequency

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 60 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    • INCLUSION CRITERIA:
    PILOTS:

    Subjects will be Chicago based pilots who fly international flights out of Chicago.

    Subjects must have worked at least 10 years as an international pilot.

    EXTERNAL COMPARISON GROUP:

    Subjects must be currently employed as university faculty from the Chicago area.

    Pilots and External Comparison Group Subjects:

    Age 35-54.

    Non-Smoker (less than 100 lifetime cigarettes).

    Male.

    EXCLUSION CRITERIA:
    PILOTS AND EXTERNAL COMPARISON GROUP SUBJECTS:

    No personal history of cancer.

    No history of chemotherapy.

    No history of major diagnostic radiation therapy (e.g., radio-imaging that exposed the large bones or lymph nodes except for routine medical and dental x-rays).

    No family history of hereditary diseases (ataxia telangiectasia, Fanconi's anemia, Bloom's syndrome, and xeroderma pigmentosum).

    EXTERNAL COMPARISON GROUP SUBJECTS:

    Must not have a history of excessive past air travel (defined as no more than an average of one international flight/year and one domestic flight/month).

    No history of major illnesses, such as heart disease and diabetes.

    Must not have been employed in a clinical or laboratory area that involves exposure to radiation and chemotherapeutic drugs.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Institute for Occupational Safety and Health Cincinnati Ohio United States 26505-2888

    Sponsors and Collaborators

    • National Cancer Institute (NCI)
    • Centers for Disease Control and Prevention
    • National Institute for Occupational Safety and Health (NIOSH/CDC)

    Investigators

    • Principal Investigator: Mark P Little, Ph.D., National Cancer Institute (NCI)

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    National Cancer Institute (NCI)
    ClinicalTrials.gov Identifier:
    NCT00341900
    Other Study ID Numbers:
    • 999902043
    • 02-C-N043
    First Posted:
    Jun 21, 2006
    Last Update Posted:
    Apr 7, 2020
    Last Verified:
    Apr 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by National Cancer Institute (NCI)
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 7, 2020